Kyowa Hakko Kogyo Report issue

For profit Phase 3 Phase 4
Founded: Tokyo Japan (1949)
Status: Acquired by Kyowa Hakko Kirin (2008)

Organization Overview

First Clinical Trial
2002
NCT00147316
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kyowa Hakko | Kyowa Hakko Bio Co., Ltd. | Kyowa Hakko Kogyo Co. | Kyowa Hakko Kogyo Co., Ltd. | Kyowa Hakko Kogyo (Japan) providing the amino acids

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Ischemia (Phase 3)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 3)

Infarction (Phase 3)

Ischemia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 11